Siegel Jolie
Insider CIK 1768223 · CCCC Chief Legal Officer · NTGN VP, General Counsel
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2025-02-14 | 2025-02-18 | 84,700 | — | $0 | 84,700 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | F Tax w/h | 2025-02-14 | 2025-02-18 | 2,914 | $3.18 | $9.3K | 107,939 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award | 2025-02-14 | 2025-02-18 | 56,500 | — | $0 | 110,853 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | F Tax w/h | 2025-02-13 | 2025-02-18 | 2,135 | $3.20 | $6.8K | 54,353 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2024-11-07 | 2024-11-12 | 3,750 | — | $0 | 10,500 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2024-11-07 | 2024-11-12 | 3,750 | — | $0 | 57,590 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | F Tax w/h | 2024-11-07 | 2024-11-12 | 1,102 | $6.04 | $6.7K | 56,488 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2024-09-16 | 2024-09-17 | 2,250 | — | $0 | 14,250 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2024-09-16 | 2024-09-17 | 2,250 | — | $0 | 54,501 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | F Tax w/h | 2024-09-16 | 2024-09-17 | 661 | $6.36 | $4.2K | 53,840 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | D To issuer deriv | 2024-03-07 | 2024-03-08 | 84,850 | — | $0 | 0 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2024-03-07 | 2024-03-08 | 84,850 | — | $0 | 84,850 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | D To issuer deriv | 2024-03-07 | 2024-03-08 | 90,000 | — | $0 | 0 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2024-03-07 | 2024-03-08 | 90,000 | — | $0 | 90,000 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2024-02-14 | 2024-02-15 | 122,800 | — | $0 | 122,800 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award | 2024-02-14 | 2024-02-15 | 27,300 | — | $0 | 52,251 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | F Tax w/h | 2024-02-13 | 2024-02-15 | 1,735 | $6.53 | $11.3K | 24,951 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2023-09-18 | 2023-09-19 | 120,000 | — | $0 | 120,000 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2023-08-30 | 2023-08-31 | 2,250 | — | $0 | 16,500 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | F Tax w/h | 2023-08-30 | 2023-08-31 | 661 | $2.93 | $1.9K | 26,686 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2023-08-30 | 2023-08-31 | 2,250 | — | $0 | 27,347 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2023-02-13 | 2023-02-15 | 90,000 | — | $0 | 90,000 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award | 2023-02-13 | 2023-02-15 | 20,000 | — | $0 | 25,097 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2023-01-30 | 2023-02-01 | 3,750 | — | $0 | 18,750 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2023-01-30 | 2023-02-01 | 3,750 | — | $0 | 6,398 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | F Tax w/h | 2023-01-30 | 2023-02-01 | 1,301 | $7.78 | $10.1K | 5,097 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | F Tax w/h | 2022-05-26 | 2022-06-14 | 1,102 | $7.01 | $7.7K | 2,648 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2022-05-25 | 2022-05-27 | 3,750 | — | $0 | 22,500 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2022-05-25 | 2022-05-27 | 3,750 | — | $0 | 3,750 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2022-02-14 | 2022-02-16 | 26,250 | — | $0 | 26,250 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2022-02-14 | 2022-02-16 | 90,000 | — | $0 | 90,000 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2021-09-10 | 2021-09-14 | 12,500 | — | $0 | 271,321 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | S Sale | 2021-09-10 | 2021-09-14 | 12,500 | $50.00 | $625.0K | 0 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2021-09-10 | 2021-09-14 | 12,500 | $4.98 | $62.3K | 12,500 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2021-07-29 | 2021-08-02 | 12,500 | — | $0 | 283,821 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2021-07-29 | 2021-08-02 | 12,500 | $4.98 | $62.3K | 12,500 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | S Sale | 2021-07-29 | 2021-08-02 | 12,500 | $45.00 | $562.5K | 0 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2021-02-11 | 2021-02-16 | 84,850 | — | $0 | 84,850 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | D To issuer deriv | 2020-05-06 | 2020-05-06 | 60,000 | — | $0 | 0 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | D To issuer deriv | 2020-05-06 | 2020-05-06 | 100,000 | — | $0 | 0 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | D To issuer | 2020-05-06 | 2020-05-06 | 161,821 | — | $0 | 0 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | F Tax w/h | 2020-02-29 | 2020-03-02 | 2,845 | $1.50 | $4.3K | 161,821 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | F Tax w/h | 2020-02-25 | 2020-02-27 | 5,334 | $1.51 | $8.1K | 164,666 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | A Award | 2020-01-12 | 2020-01-13 | 65,000 | — | $0 | 170,000 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | A Award | 2019-11-25 | 2019-11-25 | 75,000 | — | $0 | 105,000 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | A Award deriv | 2019-02-27 | 2019-03-01 | 60,000 | — | $0 | 60,000 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | A Award | 2019-02-27 | 2019-03-01 | 30,000 | — | $0 | 30,000 | SEC↗ |